Lenalidomide has been developed as the derivative of thalidomide that has fewer side effects. We herein report a rare case of castration-resistant prostate cancer successfully maintained using lenalidomide for multiple myeloma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799614 | PMC |
| http://dx.doi.org/10.1002/ccr3.1328 | DOI Listing |
Publication Analysis
Top Keywords
castration-resistant prostate
8
prostate cancer
8
lenalidomide decreased
4
decreased psa
4
psa level
4
level castration-resistant
4
cancer case
4
case report
4
report lenalidomide
4
lenalidomide developed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!